PharmaCoNets of Mifepristone (SPCN: 38.36 )

Drug NamePathway IDPathway nameP-valueNo. of gene membersUniProt ACGene nameDetail of Coexpression
Mifepristonehsa00020Citrate cycle (TCA cycle)3.41E-022P50213, O14521IDH3A, SDHDMore
Mifepristonehsa00030Pentose phosphate pathway5.07E-033P60891, P51854, P37837PRPS1, TKTL1, TALDO1More
Mifepristonehsa00190Oxidative phosphorylation4.36E-033Q16718, Q13488, O14521NDUFA5, TCIRG1, SDHDMore
Mifepristonehsa00220Arginine biosynthesis1.54E-022P05089, P49448ARG1, GLUD2More
Mifepristonehsa00500Starch and sucrose metabolism3.86E-023O43451, P46976, P06737MGAM, GYG1, PYGLMore
Mifepristonehsa00533Glycosaminoglycan biosynthesis - keratan sulfate3.43E-021Q9NY97B3GNT2More
Mifepristonehsa00590Arachidonic acid metabolism3.85E-022P11712, P09960CYP2C9, LTA4HMore
Mifepristonehsa00591Linoleic acid metabolism4.07E-021P11712CYP2C9More
Mifepristonehsa00630Glyoxylate and dicarboxylate metabolism1.29E-022P40925, P15104MDH1, GLULMore
Mifepristonehsa00790Folate biosynthesis4.05E-022Q92820, P42330GGH, AKR1C3More
Mifepristonehsa00910Nitrogen metabolism2.93E-022P22748, P49448CA4, GLUD2More
Mifepristonehsa00970Aminoacyl-tRNA biosynthesis5.32E-033O95363, P54136, Q15046FARS2, RARS1, KARSMore
Mifepristonehsa00980Metabolism of xenobiotics by cytochrome P4509.14E-032P78417, P11712GSTO1, CYP2C9More
Mifepristonehsa00982Drug metabolism - cytochrome P4509.14E-032P11712, P78417CYP2C9, GSTO1More
Mifepristonehsa00983Drug metabolism - other enzymes6.37E-063P04183, P32320, P05164TK1, CDA, MPOMore
Mifepristonehsa01230Biosynthesis of amino acids3.91E-023P51854, Q99707, P50213TKTL1, MTR, IDH3AMore
Mifepristonehsa03008Ribosome biogenesis in eukaryotes1.46E-024Q9NYH9, P78345, Q9BVP2, Q9GZY0UTP6, RPP38, GNL3, NXF2; NXF2BMore
Mifepristonehsa03013RNA transport4.11E-0312P52298, Q09161, O14893, P61326, Q9GZY0, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5, Q53GS7NCBP2, NCBP1, GEMIN2, MAGOH, NXF2; NXF2B, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3, GLE1More
Mifepristonehsa03015mRNA surveillance pathway9.78E-036O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1More
Mifepristonehsa04060Cytokine-cytokine receptor interaction1.74E-0417P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25More
Mifepristonehsa04061Viral protein interaction with cytokine and cytokine receptor3.36E-049P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNFMore
Mifepristonehsa04062Chemokine signaling pathway5.37E-039P25024, P09341, P19875, P07948, P42338, P19174, P63218, P50151, P43250CXCR1, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6More
Mifepristonehsa04064NF-kappa B signaling pathway1.86E-1022P10415, Q13489, P25963, P51617, O00463, Q13546, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, O75293, P09341, P19875, Q06643, Q9UNE0BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, RIPK1, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB, EDARMore
Mifepristonehsa04071Sphingolipid signaling pathway6.18E-059P17252, P21453, Q9H228, P01375, Q13362, Q16537, Q9BX95, P04637, P10415PRKCA, S1PR1, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, TP53, BCL2More
Mifepristonehsa04080Neuroactive ligand-receptor interaction1.83E-048P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1More
Mifepristonehsa04114Oocyte meiosis1.33E-024P51812, Q02750, P16298, Q17RY0RPS6KA3, MAP2K1, PPP3CB, CPEB4More
Mifepristonehsa04115p53 signaling pathway3.57E-025P24522, Q13315, Q53FA7, O95067, P10415GADD45A, ATM, TP53I3, CCNB2, BCL2More
Mifepristonehsa04145Phagosome4.31E-0611P63261, Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765ACTG1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOBMore
Mifepristonehsa04150mTOR signaling pathway3.60E-023Q02750, Q9NQL2, P51812MAP2K1, RRAGD, RPS6KA3More
Mifepristonehsa04210Apoptosis1.09E-0312Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, P18848, Q14643ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ATF4, ITPR1More
Mifepristonehsa04211Longevity regulating pathway1.18E-023Q12778, Q9UEF7, Q96KQ7FOXO1, KL, EHMT2More
Mifepristonehsa04213Longevity regulating pathway - multiple species3.85E-024P42338, Q9Y4H2, P11142, Q13547PIK3CB, IRS2, HSPA8, HDAC1More
Mifepristonehsa04215Apoptosis - multiple species1.56E-022Q13489, P10415BIRC3, BCL2More
Mifepristonehsa04217Necroptosis2.93E-023P01568, Q13489, Q13546IFNA21, BIRC3, RIPK1More
Mifepristonehsa04340Hedgehog signaling pathway4.63E-023P22694, Q13635, P10415PRKACB, PTCH1, BCL2More
Mifepristonehsa04370VEGF signaling pathway2.68E-033P16298, Q05397, Q02750PPP3CB, PTK2, MAP2K1More
Mifepristonehsa04390Hippo signaling pathway2.08E-023P84022, Q13485, Q13489SMAD3, SMAD4, BIRC3More
Mifepristonehsa04530Tight junction3.29E-023P16989, P56750, Q14247CSDA, CLDN17, CTTNMore
Mifepristonehsa04540Gap junction3.53E-024P17252, Q13509, P68371, Q14643PRKCA, TUBB3, TUBB2C, ITPR1More
Mifepristonehsa04612Antigen processing and presentation1.41E-078P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNFMore
Mifepristonehsa04613Neutrophil extracellular trap formation9.71E-0718P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, P21730, P21462, P63261PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1, ACTG1More
Mifepristonehsa04620Toll-like receptor signaling pathway4.16E-022Q13546, P01568RIPK1, IFNA21More
Mifepristonehsa04621NOD-like receptor signaling pathway7.18E-0413Q14643, P01568, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q13546, Q05823, P01375, P49913, P12838ITPR1, IFNA21, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RIPK1, RNASEL, TNF, CAMP, DEFA4More
Mifepristonehsa04622RIG-I-like receptor signaling pathway2.39E-022P01568, Q13546IFNA21, RIPK1More
Mifepristonehsa04623Cytosolic DNA-sensing pathway2.20E-032P01568, Q13546IFNA21, RIPK1More
Mifepristonehsa04640Hematopoietic cell lineage2.66E-0413P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNFMore
Mifepristonehsa04650Natural killer cell mediated cytotoxicity2.53E-0914P16298, P50591, P19174, P01375, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O75015, P26717, P26715PPP3CB, TNFSF10, PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1More
Mifepristonehsa04657IL-17 signaling pathway8.05E-047O00463, Q16539, P49841, P09341, P14780, P80188, P01375TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNFMore
Mifepristonehsa04658Th1 and Th2 cell differentiation8.53E-1214Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3More
Mifepristonehsa04659Th17 cell differentiation1.46E-0917P25963, Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P84022, Q13485, P07766, P09693, P20963NFKBIA, PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD3, SMAD4, CD3E, CD3G, CD247More
Mifepristonehsa04660T cell receptor signaling pathway8.34E-0818P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3BMore
Mifepristonehsa04662B cell receptor signaling pathway1.07E-025P42338, P60033, P07948, P21854, Q8N149PIK3CB, CD81, LYN, CD72, LILRA2More
Mifepristonehsa04664Fc epsilon RI signaling pathway1.29E-024P42338, P07948, P19174, P09917PIK3CB, LYN, PLCG1, ALOX5More
Mifepristonehsa04666Fc gamma R-mediated phagocytosis9.96E-035P23528, P49006, P06396, P14598, P17252CFL1, MARCKSL1, GSN, NCF1, PRKCAMore
Mifepristonehsa04668TNF signaling pathway2.36E-039P01375, O00463, Q13489, Q16539, P25963, P09341, P20749, Q13077, P14780TNF, TRAF5, BIRC3, MAPK14, NFKBIA, CXCL1, BCL3, TRAF1, MMP9More
Mifepristonehsa04670Leukocyte transendothelial migration4.20E-027P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXKMore
Mifepristonehsa04710Circadian rhythm1.67E-022Q16526, Q9Y478CRY1, PRKAB1More
Mifepristonehsa04720Long-term potentiation1.15E-036P16298, P51812, P18848, P22694, Q02750, Q14643PPP3CB, RPS6KA3, ATF4, PRKACB, MAP2K1, ITPR1More
Mifepristonehsa04721Synaptic vesicle cycle1.80E-022Q13488, P31645TCIRG1, SLC6A4More
Mifepristonehsa04724Glutamatergic synapse2.81E-024P43003, P63218, P50151, P15104SLC1A3, GNG5, GNG10, GLULMore
Mifepristonehsa04725Cholinergic synapse3.86E-024P22694, Q14643, P18848, P10415PRKACB, ITPR1, ATF4, BCL2More
Mifepristonehsa04750Inflammatory mediator regulation of TRP channels4.06E-038P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQMore
Mifepristonehsa04912GnRH signaling pathway2.62E-023P18848, Q14643, P22694ATF4, ITPR1, PRKACBMore
Mifepristonehsa04913Ovarian steroidogenesis4.05E-022P42330, P22694AKR1C3, PRKACBMore
Mifepristonehsa04914Progesterone-mediated oocyte maturation2.94E-023Q17RY0, P51812, Q02750CPEB4, RPS6KA3, MAP2K1More
Mifepristonehsa04915Estrogen signaling pathway1.67E-035P14780, P22694, P18848, Q14643, P10415MMP9, PRKACB, ATF4, ITPR1, BCL2More
Mifepristonehsa04918Thyroid hormone synthesis7.24E-043P22694, P18848, Q14643PRKACB, ATF4, ITPR1More
Mifepristonehsa04920Adipocytokine signaling pathway5.84E-036P25963, P33121, Q9Y478, Q04759, Q96RR4, P01375NFKBIA, ACSL1, PRKAB1, PRKCQ, CAMKK2, TNFMore
Mifepristonehsa04922Glucagon signaling pathway2.11E-024P22694, P06737, P18848, Q14643PRKACB, PYGL, ATF4, ITPR1More
Mifepristonehsa04925Aldosterone synthesis and secretion4.95E-023Q14643, P18848, P22694ITPR1, ATF4, PRKACBMore
Mifepristonehsa04927Cortisol synthesis and secretion3.17E-053Q14643, P18848, P22694ITPR1, ATF4, PRKACBMore
Mifepristonehsa04928Parathyroid hormone synthesis, secretion and action9.12E-045Q14643, P22694, P23771, P18848, P10415ITPR1, PRKACB, GATA3, ATF4, BCL2More
Mifepristonehsa04933AGE-RAGE signaling pathway in diabetic complications1.25E-023P84022, Q13485, P10415SMAD3, SMAD4, BCL2More
Mifepristonehsa04934Cushing syndrome4.06E-025Q14643, P22694, P49841, Q9UJU2, O00170ITPR1, PRKACB, GSK3B, LEF1, AIPMore
Mifepristonehsa04964Proximal tubule bicarbonate reclamation2.93E-022P22748, P49448CA4, GLUD2More
Mifepristonehsa04970Salivary secretion4.49E-024P22694, Q14643, P17252, P49913PRKACB, ITPR1, PRKCA, CAMPMore
Mifepristonehsa04972Pancreatic secretion1.99E-023Q14643, P20020, P17252ITPR1, ATP2B1, PRKCAMore
Mifepristonehsa04973Carbohydrate digestion and absorption1.29E-022O43451, P42338MGAM, PIK3CBMore
Mifepristonehsa04975Fat digestion and absorption9.50E-041O14494PLPP1More
Mifepristonehsa05034Alcoholism2.89E-034Q93077, P62807, O60814, P68431HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12More
Mifepristonehsa05120Epithelial cell signaling in Helicobacter pylori infection2.78E-035P09341, P19875, P19174, P25024, P07948CXCL1, CXCL2, PLCG1, CXCR1, LYNMore
Mifepristonehsa05131Shigellosis3.34E-0211P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPFMore
Mifepristonehsa05132Salmonella infection1.81E-0515P51617, P25963, P01375, Q9UJU2, P63261, Q13546, Q13489, P10415, Q96A32, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371IRAK1, NFKBIA, TNF, LEF1, ACTG1, RIPK1, BIRC3, BCL2, MYLPF, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2CMore
Mifepristonehsa05134Legionellosis1.29E-024P11215, P11142, P09341, P19875ITGAM, HSPA8, CXCL1, CXCL2More
Mifepristonehsa05135Yersinia infection4.26E-026P13612, P06239, Q16539, P01375, P49841, P01732ITGA4, LCK, MAPK14, TNF, GSK3B, CD8AMore
Mifepristonehsa05140Leishmaniasis3.13E-059P14598, P13765, O60603, P25963, P01375, P29350, P49006, P51617, Q15080NCF1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, IRAK1, NCF4More
Mifepristonehsa05144Malaria1.80E-024O60603, P01375, P35443, P26718TLR2, TNF, THBS4, KLRK1More
Mifepristonehsa05145Toxoplasmosis4.06E-037P51617, P25963, P01375, P10415, Q13489, P13765, O60603IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2More
Mifepristonehsa05146Amoebiasis1.05E-0813Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSGMore
Mifepristonehsa05152Tuberculosis3.11E-039Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1More
Mifepristonehsa05161Hepatitis B1.61E-0310P17252, P14780, P25963, Q13485, P01375, P10415, P84022, P51617, O60603, Q14765PRKCA, MMP9, NFKBIA, SMAD4, TNF, BCL2, SMAD3, IRAK1, TLR2, STAT4More
Mifepristonehsa05163Human cytomegalovirus infection2.64E-027P42338, P63218, P50151, P01106, P14778, Q13651, P30101PIK3CB, GNG5, GNG10, MYC, IL1R1, IL10RA, PDIA3More
Mifepristonehsa05167Kaposi sarcoma-associated herpesvirus infection4.22E-0412P42338, P62879, P63218, P50151, P09341, P19875, P19174, P16298, Q02750, P07948, P01106, P0CG47PIK3CB, GNB2, GNG5, GNG10, CXCL1, CXCL2, PLCG1, PPP3CB, MAP2K1, LYN, MYC, UBBMore
Mifepristonehsa05169Epstein-Barr virus infection1.27E-029P01106, Q13547, P42338, P07948, P30101, Q13761, O75293, P07766, P20963MYC, HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CD3E, CD247More
Mifepristonehsa05170Human immunodeficiency virus 1 infection3.39E-0626P42338, Q02750, P62879, P63218, P50151, P16298, P01375, Q05397, P17252, O00463, P30101, Q14643, P01730, P51617, P25963, O60603, Q13315, O95067, P19174, P07766, P20963, P10415, Q13619, Q93034, Q9Y6Q5, P20333PIK3CB, MAP2K1, GNB2, GNG5, GNG10, PPP3CB, TNF, PTK2, PRKCA, TRAF5, PDIA3, ITPR1, CD4, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CD3E, CD247, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1BMore
Mifepristonehsa05202Transcriptional misregulation in cancer1.02E-0919Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P24522FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45AMore
Mifepristonehsa05203Viral carcinogenesis4.85E-023Q15283, P62807, O60814RASA2, HIST1H2BC, H2BC12More
Mifepristonehsa05204Chemical carcinogenesis1.48E-022P78417, P11712GSTO1, CYP2C9More
Mifepristonehsa05205Proteoglycans in cancer2.66E-028Q14643, P63261, P04637, P14780, P17252, O60603, Q13635, P08962ITPR1, ACTG1, TP53, MMP9, PRKCA, TLR2, PTCH1, CD63More
Mifepristonehsa05210Colorectal cancer1.78E-023P84022, Q13485, P10415SMAD3, SMAD4, BCL2More
Mifepristonehsa05212Pancreatic cancer3.52E-022P84022, Q13485SMAD3, SMAD4More
Mifepristonehsa05213Endometrial cancer3.79E-022O15169, Q02750AXIN1, MAP2K1More
Mifepristonehsa05216Thyroid cancer3.59E-023Q9UJU2, P04637, P24522LEF1, TP53, GADD45AMore
Mifepristonehsa05217Basal cell carcinoma1.20E-035Q13635, P49841, Q9UJU2, P04637, P24522PTCH1, GSK3B, LEF1, TP53, GADD45AMore
Mifepristonehsa05220Chronic myeloid leukemia1.25E-023Q13485, P25963, P84022SMAD4, NFKBIA, SMAD3More
Mifepristonehsa05222Small cell lung cancer2.38E-036Q13489, P10415, P25963, Q13077, O00463, P24522BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45AMore
Mifepristonehsa05226Gastric cancer4.33E-035Q02750, O15169, P84022, Q13485, P10415MAP2K1, AXIN1, SMAD3, SMAD4, BCL2More
Mifepristonehsa05235PD-L1 expression and PD-1 checkpoint pathway in cancer6.30E-0510P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, Q16539, P01730PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, CD4More
Mifepristonehsa05310Asthma6.09E-073P13765, P12724, P01375HLA-DOB, RNASE3, TNFMore
Mifepristonehsa05321Inflammatory bowel disease6.54E-117O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21RMore
Mifepristonehsa05322Systemic lupus erythematosus3.30E-0514P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, Q16778, O60814, P68431, P12814, P05455ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1, SSBMore
Mifepristonehsa05323Rheumatoid arthritis2.32E-035P01375, P13765, P10747, P09341, O60603TNF, HLA-DOB, CD28, CXCL1, TLR2More
Mifepristonehsa05332Graft-versus-host disease8.48E-085P13765, P10747, P01375, P26715, Q13241HLA-DOB, CD28, TNF, KLRC1, KLRD1More
Mifepristonehsa05418Fluid shear stress and atherosclerosis4.26E-026P14598, P14780, P63261, P04637, P10415, Q92974NCF1, MMP9, ACTG1, TP53, BCL2, ARHGEF2More

Community members of Mifepristone (SDC: 3.05)

UniProtACGene NameProtein NameReported/
Predicted
DisGeNETSPVSdrugabilitySHiSBiNSDisG
O75469NR1I2Nuclear receptor subfamily 1 group I member 2Reported10.03150.949301.9143
P08235NR3C2Mineralocorticoid receptorPredicted10.185510.01372.1064
P11712CYP2C9Cytochrome P450 2C9Predicted10.010610.15242.1577
P49336CDK8CyclinNonedependent kinase 8Predicted00.13560.64701.3618
Q13093PLA2G7PlateletNoneactivating factor acetylhydrolasePredicted00.05050.20960.15580.6001
P11511CYP19A1AromatasePredicted00.815610.15882.5666
P49863GZMKGranzyme KPredicted00.01070.032500.0704
P10826RARBRetinoic acid receptor betaPredicted00.00940.34660.30050.9983
P24158PRTN3MyeloblastinPredicted10.05160.051100.1281
P08311CTSGCathepsin GPredicted00.49490.18740.64781.2701
P20160AZU1AzurocidinPredicted00.370.0130.42670.6377
P51124GZMMGranzyme MPredicted00.05280.030100.0867
P08246ELA2Neutrophil elastasePredicted10.4960.68440.71322.33
This pair is Reported in Drugbank.
Gene nameUniProt_IDBioactivityValue (nM)